Sarepta Therapeutics (SRPT) Other Non Operating Income (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Other Non Operating Income of -$15.3 million for Q1 2026, up 81.64% year-over-year from -$8.4 million in Q1 2025, and up 90.34% quarter-over-quarter from -$157.9 million in Q4 2025.
Sarepta Therapeutics (SRPT) Other Non Operating Income (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$15.3 million for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 81.64% year-over-year to -$15.3 million; the TTM figure through Mar 2026 stood at $3.5 million (up 103.44% YoY), while the FY2025 annual figure was -$19.3 million, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$15.3 million, up from -$157.9 million in the prior quarter.
- The five-year high for Other Non Operating Income was $387.3 million in Q1 2023, with the low at -$157.9 million in Q4 2025.
- The 5-year median for Other Non Operating Income is $5.5 million (2022), against an average of $28.1 million.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income tumbled 27076.56% in 2022, then jumped 2343.27% in 2023.
- Sarepta Therapeutics' Other Non Operating Income stood at $5.5 million in 2022, then jumped by 6907.42% to $387.3 million in 2023, then sank by 108.43% to -$32.6 million in 2024, then slumped by 383.91% to -$157.9 million in 2025, then surged by 90.34% to -$15.3 million in 2026.
- Business Quant data shows SRPT's Other Non Operating Income at -$15.3 million in Q1 2026, -$157.9 million in Q4 2025, and $138.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.04 Mn |
| Mar 31, 2026 | -15.26 Mn |
| Dec 31, 2025 | -157.91 Mn |
| Sep 30, 2025 | 138.60 Mn |
| Jun 30, 2025 | 38.06 Mn |
| Mar 31, 2025 | -83.13 Mn |
| Dec 31, 2024 | -32.63 Mn |
| Jun 30, 2024 | 14.28 Mn |
| Mar 31, 2024 | 6.54 Mn |
| Mar 31, 2023 | 387.30 Mn |
| Dec 31, 2022 | 5.53 Mn |
| Sep 30, 2022 | 98.50 Mn |
| Jun 30, 2022 | -16.96 Mn |
| Mar 31, 2022 | -17.27 Mn |
| Dec 31, 2021 | -60.58 Mn |
| Jun 30, 2021 | -406,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 160,000.00 |
| Sep 30, 2020 | -881,000.00 |
| Jun 30, 2020 | -371,000.00 |